Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06230523 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT06230523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06230523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2024
Completion date
August 14, 2025
Enrollment
263 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight